NZ608598A - A transdermal drug administration device - Google Patents

A transdermal drug administration device

Info

Publication number
NZ608598A
NZ608598A NZ60859811A NZ60859811A NZ608598A NZ 608598 A NZ608598 A NZ 608598A NZ 60859811 A NZ60859811 A NZ 60859811A NZ 60859811 A NZ60859811 A NZ 60859811A NZ 608598 A NZ608598 A NZ 608598A
Authority
NZ
New Zealand
Prior art keywords
administration device
drug administration
transdermal drug
force
delivery element
Prior art date
Application number
NZ60859811A
Other languages
English (en)
Inventor
Håkan Engqvist
Susanne Bredenberg
Anders Pettersson
Thomas Lundqvist
Anna Dahlgren
Anders Sågström
Original Assignee
Orexo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo Ab filed Critical Orexo Ab
Publication of NZ608598A publication Critical patent/NZ608598A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ60859811A 2010-09-07 2011-09-05 A transdermal drug administration device NZ608598A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38053910P 2010-09-07 2010-09-07
PCT/GB2011/051658 WO2012032337A2 (en) 2010-09-07 2011-09-05 A transdermal drug administration device

Publications (1)

Publication Number Publication Date
NZ608598A true NZ608598A (en) 2015-03-27

Family

ID=44764181

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ60859811A NZ608598A (en) 2010-09-07 2011-09-05 A transdermal drug administration device

Country Status (12)

Country Link
US (2) US10251834B2 (cg-RX-API-DMAC10.html)
EP (1) EP2613784B1 (cg-RX-API-DMAC10.html)
JP (1) JP5843864B2 (cg-RX-API-DMAC10.html)
KR (2) KR20140003405A (cg-RX-API-DMAC10.html)
AU (1) AU2011300524B2 (cg-RX-API-DMAC10.html)
CA (1) CA2809927C (cg-RX-API-DMAC10.html)
DK (1) DK2613784T3 (cg-RX-API-DMAC10.html)
ES (1) ES2658913T3 (cg-RX-API-DMAC10.html)
NO (1) NO2613784T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ608598A (cg-RX-API-DMAC10.html)
PL (1) PL2613784T3 (cg-RX-API-DMAC10.html)
WO (1) WO2012032337A2 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1011412A8 (pt) * 2009-05-08 2018-01-02 Orexo Ab composição para liberação sustentada de droga compreendendo aglutinante geopolimérico
ES2908958T3 (es) 2013-02-01 2022-05-04 Grace W R & Co Gel de sílice porosa como portador para tecnologías líquidas
WO2016049266A1 (en) * 2014-09-24 2016-03-31 Pain Therapeutics, Inc. 4:3 naltrexone: 5-methyl-2-furaldehyde cocrystal
EP3207923B1 (en) * 2014-10-14 2019-09-04 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
GB201503961D0 (en) * 2015-03-09 2015-04-22 Emplicure Ab A transdermal drug administration device
CN109069770A (zh) * 2016-02-29 2018-12-21 埃姆普里居公司 用于蒸发和吸入尼古丁的装置
KR101719319B1 (ko) * 2016-04-05 2017-03-23 주식회사 엘지생활건강 효율적인 피부 천공을 위한 마이크로니들 구조
US9650338B1 (en) 2016-07-29 2017-05-16 VDM Biochemicals, Inc. Opioid antagonist compounds and methods of making and using
CN106265584B (zh) * 2016-08-31 2019-04-09 浙江工业大学 埃洛石纳米管为骨架的肠溶复合载药体系及其制备方法
CN116873874A (zh) 2017-04-18 2023-10-13 突破技术有限责任公司 硫的生产
BR112020010729A2 (pt) 2017-12-14 2020-11-10 Lts Lohmann Therapie-Systeme Ag arranjo de microagulhas compreendendo ingrediente ativo na forma de sais
CN110448543A (zh) * 2019-09-16 2019-11-15 临沂大学 一种基于埃洛石纳米管/壳聚糖复合骨架的绿原酸肠溶缓释微球及其制备方法
WO2021161205A1 (en) * 2020-02-13 2021-08-19 Eyal Research Consultants Ltd Microbial combinations with modulators of the opioid system and uses thereof

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE93384T1 (de) 1983-11-14 1993-09-15 Univ Kentucky Res Found Poroese mikrokugeln zur arzneistoffabgabe sowie verfahren zu deren herstellung.
DE3775880D1 (cg-RX-API-DMAC10.html) 1986-09-18 1992-02-20 London School Of Pharmacy Innovations Ltd., London, Gb
IT1197316B (it) 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
JP2702953B2 (ja) 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
IT1216570B (it) 1988-04-08 1990-03-08 Vectorpharma Int Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
JPH02268104A (ja) 1989-04-07 1990-11-01 Kanebo Ltd 抗菌性組成物
US5443812A (en) 1989-04-24 1995-08-22 Kanebo Ltd. Stabilized synthetic zeolite and a process for the preparation thereof
JPH07188000A (ja) * 1993-12-27 1995-07-25 Bridgestone Corp 薬用被覆材
JPH0930988A (ja) 1995-07-21 1997-02-04 Sumitomo Osaka Cement Co Ltd 薬剤徐放性多孔質セラミックス成形体及びその製造方法
GB2307862A (en) * 1995-12-05 1997-06-11 David Jehan Patch structures for transdermal therapy
WO1998023556A1 (en) 1996-11-25 1998-06-04 Kabushiki Kaisya Advance Method of production of ceramics
US5902591A (en) 1997-04-03 1999-05-11 La Prairie Sa Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6123925A (en) 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US20030118641A1 (en) 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7011841B2 (en) 2000-03-24 2006-03-14 Mark B. Lyles High density porous materials
NZ521853A (en) 2000-04-11 2003-11-28 Sankyo Co Stabilized pharmaceutical compositions containing a calcium blocker
US6602523B1 (en) 2000-08-17 2003-08-05 Technology Holding, Llc. Composite material and process for increasing bioavailability and activity of a beneficial agent
US20020122828A1 (en) 2001-03-02 2002-09-05 Jun Liu Hybrid porous materials for controlled release
CA2440069A1 (en) 2001-03-05 2002-09-12 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
US6908622B2 (en) 2001-09-24 2005-06-21 Boston Scientific Scimed, Inc. Optimized dosing for drug coated stents
DK1429802T3 (da) 2001-09-28 2013-02-18 Tntgamble Inc Tilførselssystem for biologisk komponent
WO2003043657A1 (en) * 2001-11-19 2003-05-30 Control Delivery Systems, Inc. Topical delivery of codrugs
NZ535971A (en) 2002-04-23 2007-07-27 Alza Corp Transdermal analgesic patch with reduced abuse potential
WO2003092785A1 (en) 2002-04-30 2003-11-13 Morteza Shirkhanzadeh Arrays of microneedles comprising porous calcium phosphate coating and bioactive agents
US8062573B2 (en) * 2002-09-16 2011-11-22 Theraject, Inc. Solid micro-perforators and methods of use
SE524334C2 (sv) 2002-09-30 2004-07-27 Cerbio Tech Ab Värmegenererande biokompatibla keramiska material och förfarande för dess framställning
SE525236C2 (sv) 2002-10-31 2005-01-11 Cerbio Tech Ab Förfarande för framställning av strukturerade keramiska beläggningar och belagda anordningar framställda med detta förfarande
SE524494C2 (sv) 2002-12-31 2004-08-17 Doxa Ab Kemiskt bundna biomaterialelement med skräddarsydda egenskaper
EP1674094A4 (en) 2003-10-15 2009-12-09 Nanoegg Res Lab Inc COMPOSITION CONTAINING RETINOIC ACID NANOPARTICLES COATED WITH A VERSATILE METAL INORGANIC SALT
AU2004283644A1 (en) 2003-10-29 2005-05-06 Doxa Ab A two-step system for improved initial and final characteristics of a biomaterial
US20050181049A1 (en) 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
US20050142197A1 (en) 2003-12-31 2005-06-30 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
WO2005075016A1 (ja) 2004-02-03 2005-08-18 Hisamitsu Pharmaceutical Co., Inc. 経皮薬物投与装置用インタフェース
US7315758B2 (en) * 2004-06-03 2008-01-01 Lynntech, Inc. Transdermal delivery of therapeutic agent
JP5403912B2 (ja) 2004-06-28 2014-01-29 ベロクシス ファーマシューティカルズ エー／エス 液体製剤用担体としての多孔性錠剤
KR20070042177A (ko) 2004-07-13 2007-04-20 알타이어나노 인코포레이티드 약물의 조절 방출을 위한 세라믹 구조체
KR20070042176A (ko) 2004-07-13 2007-04-20 알타이어나노 인코포레이티드 약물 전용의 방지를 위한 세라믹 구조체
US7537590B2 (en) * 2004-07-30 2009-05-26 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
WO2006023286A2 (en) 2004-08-19 2006-03-02 Alza Corporation Controlled release nanoparticle active agent formulation dosage forms and methods
US8535702B2 (en) 2005-02-01 2013-09-17 Boston Scientific Scimed, Inc. Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
FR2881652B1 (fr) 2005-02-08 2007-05-25 Flamel Technologies Sa Forme pharmaceutique orale microparticulaire anti-mesuage
WO2006096544A1 (en) 2005-03-04 2006-09-14 Altairnano, Inc. Ceramic structures for controlled release of biologically active substances
DE102005040429A1 (de) 2005-08-25 2007-03-01 Heraeus Kulzer Gmbh Wirkstofffreisetzungssystem und seine Verwendung
US8652529B2 (en) 2005-11-10 2014-02-18 Flamel Technologies Anti-misuse microparticulate oral pharmaceutical form
US7682445B2 (en) 2005-12-08 2010-03-23 Doxa Ab Powdered CBC system with improved reaction feature
US20090104286A1 (en) 2005-12-29 2009-04-23 Robert Basic Regulation of allergic reaction
US20080200262A1 (en) 2006-01-20 2008-08-21 David Whitby Video game instruction card holder
US20070212414A1 (en) 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
US20070248656A1 (en) 2006-04-25 2007-10-25 Galer Bradley S Topical preparation dispensers and methods of using the same
US9023400B2 (en) 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
DE102006028781A1 (de) 2006-06-23 2007-12-27 Robert Bosch Gmbh Verfahren zur Herstellung von porösen Mikronadeln und ihre Verwendung
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US8778377B2 (en) 2007-03-01 2014-07-15 Doxa Ab Drug implant carrier for drug delivery
EP2131878A4 (en) 2007-03-01 2012-12-26 Doxa Ab INJECTABLE CEMENT COMPOSITION FOR ORTHOPEDIC AND DENTAL PURPOSES
WO2008105737A1 (en) 2007-03-01 2008-09-04 Doxa Ab Stable cement composition for orthopaedic and dental use
WO2008118096A1 (en) 2007-03-28 2008-10-02 Doxa Ab Carriers for drug delivery
CN101104080B (zh) 2007-04-24 2011-06-22 深圳市鸿华投资有限公司 沸石止血敷料及其制备方法和用途
GB0709541D0 (en) 2007-05-17 2007-06-27 Jagotec Ag Pharmaceutical excipient
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
WO2010096704A2 (en) 2009-02-19 2010-08-26 Alex Garfield Bonner Porous interpenetrating polymer network

Also Published As

Publication number Publication date
EP2613784A2 (en) 2013-07-17
KR20140003405A (ko) 2014-01-09
AU2011300524A1 (en) 2013-02-21
JP2013536875A (ja) 2013-09-26
CA2809927A1 (en) 2012-03-15
DK2613784T3 (da) 2018-01-29
NO2613784T3 (cg-RX-API-DMAC10.html) 2018-05-12
ES2658913T3 (es) 2018-03-12
US10736838B2 (en) 2020-08-11
EP2613784B1 (en) 2017-12-13
KR102084571B1 (ko) 2020-03-04
WO2012032337A2 (en) 2012-03-15
US20190282494A1 (en) 2019-09-19
JP5843864B2 (ja) 2016-01-13
US10251834B2 (en) 2019-04-09
AU2011300524B2 (en) 2014-10-23
PL2613784T3 (pl) 2018-05-30
KR20180018840A (ko) 2018-02-21
WO2012032337A3 (en) 2012-04-26
US20130273119A1 (en) 2013-10-17
CA2809927C (en) 2019-08-20

Similar Documents

Publication Publication Date Title
NZ608598A (en) A transdermal drug administration device
MY163809A (en) Transdermal drug delivery system containing donepezil
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
MX2022006681A (es) Sistema de suministro transdermico de donepezilo.
EP2258441A3 (en) Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs
WO2009029958A3 (en) Implantable delivery device
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
NZ704011A (en) Abuse deterrent pharmaceutical compositions for controlled release
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
NZ605469A (en) Nalbuphine-based formulations and uses thereof
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
WO2012009684A3 (en) Drug delivery medical device
MX356111B (es) Composiciones farmaceuticas disuasorias de abuso, de liberacion inmediata.
IN2012DN01225A (cg-RX-API-DMAC10.html)
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
AR072492A1 (es) Dispositivo y administracion transdermica de estrogeno
MY183873A (en) Transdermal therapeutic system for application of an agent
MX366230B (es) Composiciones multipolimericas para liberación transdermica de farmaco.
EP4238580A3 (en) Transdermal delivery system including an interface mediator
IN2014DN09817A (cg-RX-API-DMAC10.html)
PL3655364T3 (pl) Zastosowanie materiału nośnikowego w układzie dostarczania do uwalniania jednego lub większej liczby środków czynnych w preparacie do pielęgnacji domowej
WO2008151040A3 (en) Analgesic coated medical product
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
MX2023007741A (es) Formulaciones de upadacitinib de liberacion prolongada.
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2016 BY RENEWALS TEAM

Effective date: 20150820

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2017 BY RENEWALS TEAM

Effective date: 20160827

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2018 BY RENEWALS TEAM

Effective date: 20170826

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2019 BY RENEWALS TEAM

Effective date: 20180818

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2020 BY RENEWALS TEAM

Effective date: 20190902

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2021 BY RENEWALS TEAM

Effective date: 20200905

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2022 BY ENVOY

Effective date: 20210901

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 SEP 2023 BY ENVOY

Effective date: 20220902

LAPS Patent lapsed